{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:05:55Z","timestamp":1783069555076,"version":"3.54.6"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.contraception.2021.04.027","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T04:28:42Z","timestamp":1620448122000},"page":"61-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks\u2019 gestation at British Pregnancy Advisory Service: A cross-sectional evaluation"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2070-5350","authenticated-orcid":false,"given":"Marielle E.","family":"Meurice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3283-3803","authenticated-orcid":false,"given":"Katherine C.","family":"Whitehouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-1638","authenticated-orcid":false,"given":"Rebecca","family":"Blaylock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6755-8928","authenticated-orcid":false,"given":"Jenny J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Lohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2021.04.027_bib0001","unstructured":"Medication Abortion and the Changing Abortion Landscape | Guttmacher Institute n.d. https:\/\/www.guttmacher.org\/article\/2019\/09\/medication-abortion-and-changing-abortion-landscape# (accessed October 18, 2020)."},{"key":"10.1016\/j.contraception.2021.04.027_bib0002","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.contraception.2012.10.021","article-title":"Acceptability of home use of mifepristone for medical abortion","volume":"88","author":"Swica","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.027_bib0003","unstructured":"Abortion Act 1967. Statute law database; n.d."},{"key":"10.1016\/j.contraception.2021.04.027_bib0004","unstructured":"Baxter T. The Abortion Act 1967-approval of a class of places. 2018."},{"key":"10.1016\/j.contraception.2021.04.027_bib0005","unstructured":"Information for healthcare professionals Coronavirus (COVID-19) infection and abortion care. 2020."},{"key":"10.1016\/j.contraception.2021.04.027_bib0006","unstructured":"Davies M. The Abortion Act 1967-approval of a class of places. 2020."},{"key":"10.1016\/j.contraception.2021.04.027_bib0007","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/1471-0528.15684","article-title":"Telemedicine for medical abortion: a systematic review","volume":"126","author":"Endler","year":"2019","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2021.04.027_bib0008","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.contraception.2019.07.005","article-title":"Telemedicine for medication abortion","volume":"100","author":"Upadhyay","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.027_bib0009","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/AOG.0000000000002212","article-title":"Safety of medical abortion provided through telemedicine compared with in person","volume":"130","author":"Grossman","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.04.027_bib0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.contraception.2019.05.013","article-title":"TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States","volume":"100","author":"Raymond","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.027_bib0011","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/AOG.0b013e318224d110","article-title":"Effectiveness and acceptability of medical abortion provided through telemedicine","volume":"118","author":"Grossman","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.04.027_bib0012","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12978-020-01016-4","article-title":"Self-managed medication abortion outcomes: results from a prospective pilot study","volume":"17","author":"Moseson","year":"2020","journal-title":"Reprod Health"},{"key":"10.1016\/j.contraception.2021.04.027_bib0013","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2011.11.010","article-title":"Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: a service evaluation","volume":"86","author":"Cameron","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.027_bib0014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.contraception.2015.06.026","article-title":"A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S","volume":"92","author":"Chong","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.027_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.16668","article-title":"Effectiveness, safety and acceptability of no-test medical abortion provided via telemedicine: a national cohort study","author":"Aiken","year":"2021","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2021.04.027_bib0016","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.contraception.2006.10.008","article-title":"Predictors of acceptability of medication abortion","volume":"75","author":"Teal","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.027_bib0017","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0010-7824(00)00090-1","article-title":"Predictors of analgesia use during supervised medical abortion","volume":"61","author":"Westhoff","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.027_bib0018","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/bmj.307.6906.714","article-title":"Comparison of medical abortion with surgical vacuum aspiration: Women's preferences and acceptability of treatment","volume":"307","author":"Henshaw","year":"1993","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2021.04.027_bib0019","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/AOG.0000000000002787","article-title":"Prophylactic pregabalin to decrease pain during medication abortion a randomized controlled trial","volume":"132","author":"Friedlander","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.04.027_bib0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/AOG.0000000000003576","article-title":"Opioid analgesia for medical abortion: a randomized controlled trial","volume":"134","author":"Colwill","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.04.027_bib0021","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.fertnstert.2008.01.084","article-title":"Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study","volume":"91","author":"Livshits","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2021.04.027_bib0022","first-page":"404","article-title":"Pain during medical abortion, the impact of the regimen: a neglected issue? A review","volume":"19","author":"Fiala","year":"2014","journal-title":"Eur J Contracept Reprod Heal Care"},{"key":"10.1016\/j.contraception.2021.04.027_bib0023","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1471-0528.2004.00235.x","article-title":"Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation","volume":"111","author":"Hamoda","year":"2004","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2021.04.027_bib0024","unstructured":"The Care of Women Requesting Induced Abortion The Care of Women Requesting Induced Abortion Evidence-based Clinical Guideline Number 7. 2011."},{"key":"10.1016\/j.contraception.2021.04.027_bib0025","unstructured":"Safe abortion: Technical and policy guidance for health systems second edition technical and policy guidance for health systems. 2nd ed. Geneva: World Health Organization; n.d."},{"key":"10.1016\/j.contraception.2021.04.027_bib0026","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2010.02753.x","article-title":"Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol","volume":"118","author":"Bracken","year":"2011","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2021.04.027_bib0027","doi-asserted-by":"crossref","unstructured":"Raymond EG, Bracken H. Early medical abortion without prior ultrasound \u2606 2015.","DOI":"10.1016\/j.contraception.2015.04.008"},{"key":"10.1016\/j.contraception.2021.04.027_bib0028","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2014.07.004","article-title":"The accuracy of using last menstrual period to determine gestational age for first trimester medication abortion: a systematic review","volume":"90","author":"Schonberg","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.027_bib0029","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.contraception.2017.11.005","article-title":"Simplified medical abortion screening: a demonstration project","volume":"97","author":"Raymond","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.027_bib0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijgo.2009.09.027","article-title":"Home administration of misoprostol for early medical abortion in India","volume":"108","author":"Bracken","year":"2010","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.contraception.2021.04.027_bib0031","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/1471-0528.15553","article-title":"Safety and acceptability of medical abortion through telemedicine after 9 weeks of gestation: a population-based cohort study","volume":"126","author":"Endler","year":"2019","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.contraception.2021.04.027_bib0032","first-page":"12","article-title":"Revolution in UK general practice due to COVID-19 pandemic: a cross-sectional survey","volume":"12","author":"Sharma","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.contraception.2021.04.027_bib0033","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000000897","article-title":"Mifepristone with buccal misoprostol for medical abortion","volume":"126","author":"Chen","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.04.027_bib0034","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.contraception.2015.06.011","article-title":"If we can do it for misoprostol, why not for mifepristone? the case for taking mifepristone out of the office in medical abortion","volume":"92","author":"Gold","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.027_bib0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.contraception.2015.06.020","article-title":"Reaching women where they are: eliminating the initial in-person medical abortion visit \u2606","volume":"92","author":"Raymond","year":"2015","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421001438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421001438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:18:29Z","timestamp":1757881109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782421001438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0010782421001438"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2021.04.027","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks\u2019 gestation at British Pregnancy Advisory Service: A cross-sectional evaluation","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2021.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}